★ Sign in to follow
HS

Henrik Stage

SE·Finansinspektionen
SynAct Pharma ABSynact Pharma
Total declarations
10
Companies
2
▲ Purchases (2 ops.)
€24k
▼ Sales (3 ops.)
€287k

Latest filing published 01 Mar 2021 for SynAct Pharma AB, €99k.

Filing timeline

BuySale
Henrik Stage

Insider track record

Disclosed buys
2
Disclosed sells
3
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Henrik Stage: trading record in brief

Henrik Stage discloses dealings in 2 companies, chiefly SynAct Pharma AB and Synact Pharma. Between 3 October 2017 and 26 February 2021, the trades on record add up to 10 filings.

Market trades split into 2 purchases (€24k) and 3 sales (€287k). On balance, insiders were net sellers of €263k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2021, the count stands at no purchases and 3 sales.

The record was last updated on 1 March 2021 with an open-market sale (€99k) in SynAct Pharma AB. The last insider purchase was made public on 9 May 2018, 3,105 days ago. The median gap between a trade and its publication by Finansinspektionen is 5 days. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Henrik Stage

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ▼
    Henrik Stage
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    991,345 SEK34FI-SE
    19,000 shares@ SEK 52.176128.7% of flowAktieISIN SE0008241491FI:csv-f227b0cc1f09258bf653
  • ▼
    Henrik Stage
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    1M SEK34FI-SE
    22,725 shares@ SEK 50.46433.2% of flowAktieISIN SE0008241491FI:csv-06f18b569a4315910878
  • ▼
    Henrik Stage
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    758,414 SEK27FI-SE
    15,275 shares@ SEK 49.6507100.0% of flowAktieISIN SE0008241491FI:A001Q764-1
  • ●
    Henrik Stage
    CFOExecutivesSynAct Pharma AB
    199,928 SEK20FI-SE
    29,840 shares@ SEK 6.7014.6% of flowAktieISIN SE0008241491FI:csv-516eac8332e34a102e02
  • ●
    Henrik Stage
    CFOExecutivesSynAct Pharma AB
    0FI-SE
    29,840 shares0TeckningsoptionISIN SE0013409620FI:csv-9e00b38fe30c67b9a0ff
  • ●
    Henrik Stage
    CFO/EkonomichefExecutivesSynAct Pharma AB
    185,008 SEK0FI-SE
    7,460 shares@ SEK 24.8013.4% of flowBTU (betald tecknad unit)ISIN SE0013409653FI:csv-1a11f19b503dde8dfca2
  • ●
    Henrik Stage
    CFO / EkonomichefExecutivesSynAct Pharma AB
    0FI-SE
    354,770 shares0AktieISIN SE0013409646FI:csv-c6de1704169705605cb3
  • ▲
    Henrik Stage
    CFOExecutivesSynAct Pharma AB
    200,000 SEK20FI-SE
    20,202 shares@ SEK 9.9014.5% of flowISIN SE0008241491FI:csv-955d37e8423897cacfe6
    Canonical exit: 1 Aug 2018 (T+90)
  • ●
    Henrik Stage
    CFOExecutivesSynAct Pharma AB
    0FI-SE
    380,117 shares0FI:csv-a63da51bee00132164cb
  • ▲
    Henrik Stage
    CFO of SynAct Pharma ABExecutivesSynact Pharma
    48,264 SEK27FI-SE
    7,000 shares@ SEK 6.8948100.0% of flowISIN SE0008241491FI:csv-fb23a15327ed8b95ea25
    Canonical exit: 1 Jan 2018 (T+90)

10 of 10 declarations

Related entities

No related entities found.